Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort. - Wikidata - wikimedia - TriplyDB

Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort.

Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort.

http://www.wikidata.org/entity/Q33411232

about

Lupus Nephritis: A Different Disease in European Patients?Do we still need renal biopsy in lupus nephritis?Current and emerging treatment options in the management of lupus Key issues in the management of patients with systemic lupus erythematosus: latest developments and clinical implications Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: data from a Latin American cohort.Early discoid lupus erythematosus protects against renal disease in patients with systemic lupus erythematosus: longitudinal data from a large Latin American cohort.Association of thrombotic microangiopathy and intimal hyperplasia with bleeding post-renal biopsy in antiphospholipid antibody-positive patients.Management of cardiovascular complications in systemic lupus erythematosus.Dysregulation of the microvasculature in nonlesional non-sun-exposed skin of patients with lupus nephritis.Longitudinal validation of the Brief Index of Lupus Damage.Resveratrol possesses protective effects in a pristane-induced lupus mouse model.Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006.Organ damage in high-risk patients with systemic and incomplete lupus syndromes Significant Reductions in Mortality in Hospitalized Patients with Systemic Lupus Erythematosus in Washington State from 2003 to 2011 Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus.Pattern of initial clinical manifestations of systemic lupus erythematosus in a tertiary care hospital.Developments in the clinical understanding of lupus To what extent can preventive treatments prevent damage from systemic lupus erythematosus?Damage assessment in ANCA-associated vasculitis.Global trends, potential mechanisms and early detection of organ damage in SLE.Treatment of severe lupus nephritis: the new horizon.Progress with the use of monoclonal antibodies for the treatment of systemic lupus erythematosus.Mortality in Systemic Lupus Erythematosus: an Updated Review.Current and Emerging Therapies for Lupus Nephritis.Risk of end-stage renal disease in systemic lupus erythematosus patients: a nationwide population-based study.Lupus nephritis in Latin American patients: 10-year results from a single medical center in Argentina.Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry.Renal flare prediction and prognosis in lupus nephritis Hispanic patients.Long-term renal outcomes in a cohort of 1814 Chinese patients with biopsy-proven lupus nephritis.Serum protein pattern associated with organ damage and lupus nephritis in systemic lupus erythematosus revealed by PEA immunoassay Correlation of asymptomatic hyperuricaemia and serum uric acid levels with arterial stiffness in women with systemic lupus erythematosus without clinically evident atherosclerotic cardiovascular disease.Relation of platelet C4d with all-cause mortality and ischemic stroke in patients with systemic lupus erythematosus.The American College of Rheumatology and the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus in two multiethnic cohorts: a commentary.An observational study of outcome in SLE patients with biopsy-verified glomerulonephritis between 1986 and 2004 in a defined area of southern Sweden: the clinical utility of the ACR renal response criteria and predictors for renal outcome.The clinical manifestations and survival of systemic lupus erythematosus patients in Turkey: report from two centers.Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes.Lupus Nephritis in Males: Clinical Features, Course, and Prognostic Factors for End-Stage Renal Disease.Resveratrol Role in Autoimmune Disease-A Mini-Review.Economic evaluation of lupus nephritis in the Systemic Lupus International Collaborating Clinics inception cohort using a multistate model approach.Blood oxygen level-dependent magnetic resonance imaging for detecting pathological patterns in patients with lupus nephritis: a preliminary study using gray-level co-occurrence matrix analysis.

P2860

Q26740483-5F2A456A-2C02-45F6-A9CA-A75865F4B4DF Q26741010-8EE4ACA5-7010-4F72-8D08-0F1522E266F0 Q26741266-6039283E-5D0E-459F-9956-3CFCBDB89B09 Q26775756-086E5317-64FE-4C0F-B630-E976A354A147 Q30655475-28BFDBF6-187C-4460-BE9D-F556593BC6CD Q31102783-21BB5D60-6A9A-402C-8F2E-F25C21E8FF66 Q33410947-00848D0C-9052-4136-A00E-402D290374AE Q33730536-823680EF-2194-4205-B190-EABF93BCABF7 Q33745588-EAF75952-1CE5-4E8F-B4E8-D423CC5B995D Q33801123-21C16F48-FEA5-4052-BC44-75B023680FD1 Q34681462-CDE3BD2B-22FA-4D79-9064-D00953AF1C16 Q35019423-CDA9455E-5719-49B9-96C1-BE873DA53E13 Q35600608-E33B12DE-329D-425C-ABBB-47E1A75DDC2D Q35667562-D94C7897-BA29-451C-B900-28216E4F3FD0 Q37127464-486087FF-DB57-4C9E-9867-5026CE05BE66 Q37405404-0C519409-7DA3-4018-8AB5-AB0C0DC89476 Q37453947-261B6856-9EAF-4A80-B16F-E47F6284F104 Q37879597-CF5AA058-74B0-43AB-9551-920E6CEF4997 Q38043946-829AFFEB-2BC6-4484-B481-A0AC3CE36C20 Q38066385-F4DDC7F3-9D38-4A06-BB58-BD2580E394C8 Q38271125-2EEFA275-1F3A-4054-9686-07D4E2D48933 Q38389307-B5880BFD-7B57-4254-BC6F-C57BF67B2D67 Q38777770-8CF43D11-1708-4545-A74C-47DD54A56339 Q38855495-14186DCB-974E-4455-B846-7E806C5E5E52 Q40006983-B8D55C13-8060-490B-B9EB-FB7D12B94B7A Q40619112-192F2684-CA28-4191-8672-DEE0DE268EC5 Q40831626-01155917-CAEF-49DC-AD98-6D026ECBBC5E Q41317916-F3DB344B-8E4B-4884-9BEB-2D080FD18345 Q41616353-0A60F8E8-3EA9-4F21-8CFC-DF2507D598C0 Q42281246-DF7B03FF-96F4-46EE-8EC2-E9C35B75C8DB Q43152580-6A8F497A-E911-4739-A9A6-88FF8F25E144 Q43581917-FDB8AC55-9759-45E3-AE7C-39E247859343 Q43615873-11BD7DEC-2A25-4918-83DB-F27E831B3A29 Q44371554-4016E120-769E-4DE1-B601-22ECCC02365B Q45021635-C32D91AC-6A73-4DC7-9634-D04EB330B424 Q46496211-4D57039A-E0A7-4A6C-B7D0-42936981D3A8 Q47152192-AD217EA1-EEA4-4E18-A6F2-61197BFE978D Q47158536-4E184A26-BDD0-48CC-9D04-7173E8DFF3F6 Q47385774-E7B86B9E-CD94-44D1-BE44-4CBA44755C05 Q47733503-38207926-D23B-462F-97FD-41565ADE6F17

P2860

Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort.

http://www.wikidata.org/entity/Q33411232

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Renal damage is the most impor ...... LXIV, a multiethnic US cohort.

@ast

Renal damage is the most impor ...... LXIV, a multiethnic US cohort.

@en

type

label

Renal damage is the most impor ...... LXIV, a multiethnic US cohort.

@ast

Renal damage is the most impor ...... LXIV, a multiethnic US cohort.

@en

prefLabel

Renal damage is the most impor ...... LXIV, a multiethnic US cohort.

@ast

Renal damage is the most impor ...... LXIV, a multiethnic US cohort.

@en

P1433

Q33411232-6D63B917-F187-4BB5-B3F1-35A9FF8AB239

P1476

Q33411232-224725A8-36E0-4577-B2E9-73395758C200

P2093

Q33411232-02D7974E-1466-4DED-A213-15AECAD3E0CA

Q33411232-3E93C050-7203-4FC9-8C77-DA30E32507E8

Q33411232-8D1BF426-E9E7-490C-BEA4-CAC69026606F

Q33411232-EEFD3603-439F-4A58-BFD0-36AA2C251110

P2860

Q33411232-21F481E7-470D-453B-BB3A-7873D5870775

Q33411232-27726CC4-04C3-4075-BD8E-8A971CA5D1FA

Q33411232-29C51F24-578E-46ED-A7CA-89D2551EF048

Q33411232-5444240A-2259-4FAB-8B82-790103030BB8

Q33411232-6BCC4119-C2F3-48A3-A893-3DE69C27786A

Q33411232-72AFFF80-964E-4606-934B-85ED74D503D2

Q33411232-95445319-F3C8-4426-88F4-E6965095513A

Q33411232-AF184C4C-AE82-4620-8B2A-8B68B51D3C56

Q33411232-B154903E-318C-4764-8974-DC69D99BA08A

Q33411232-BB9B53A9-F80B-4258-8F2A-85389DF8F45E

P304

Q33411232-3CE9B523-B357-4D1E-B998-165D65259A78

P31

Q33411232-EEC9C3DD-C919-4D78-A5F2-5D8EB9FC014C

P356

Q33411232-182DA793-9019-4B8E-A8EC-74DCFF9E495C

P433

Q33411232-E7D4A8FF-2D2D-4DD1-A2BD-27D980460F4A

P478

Q33411232-F1A9EF23-EEF8-4217-80CB-9B2D67261C15

P50

Q33411232-18C781FE-3D4E-4716-9148-676913225929

Q33411232-766F00BE-3FE0-4E13-90A2-567CD3D3830E

P577

Q33411232-A212E24C-BDDE-48CB-938F-422FBBDCC02A

P5875

Q33411232-FE19E628-64BB-4C81-BB51-C7801C96C756

P698

Q33411232-54F18E9F-03B2-41E2-9440-8B1E06B61690

P932

Q33411232-A339E4B0-D5A7-4EFD-BABC-D33F92488F43

P356

P1433

P1476

Renal damage is the most impor ...... LXIV, a multiethnic US cohort.

@en

P2093

Graciela S Alarcón

http://www.w3.org/2001/XMLSchema#string

Jie Zhang

http://www.w3.org/2001/XMLSchema#string

Luis M Vilá

http://www.w3.org/2001/XMLSchema#string

Maria I Danila

http://www.w3.org/2001/XMLSchema#string

P2860

The 1982 revised criteria for the classification of systemic lupus erythematosus

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Premature atherosclerosis in systemic lupus erythematosus.

Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus.

Value of a complete or partial remission in severe lupus nephritis.

Predictors of survival in systemic lupus erythematosus.

The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics".

Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group.

Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes.

Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992.

P304

542-545

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/RHEUMATOLOGY/KEP012

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

Guillermo J Pons-Estel

John D Reveille

P577

2009-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24031698

http://www.w3.org/2001/XMLSchema#string

P698

19233884

http://www.w3.org/2001/XMLSchema#string

P932

2722801

http://www.w3.org/2001/XMLSchema#string